Rivaroxaban 20 mg od is being compared with warfarin for the prevention of stroke in approximately 14 000 patients with AF in the Rivaroxaban Once daily oral direct FXa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) study. This evidence concerns the gene F10 and stroke disorder.